Drug Search Results
Using advanced filters...
Advanced Search [+]

Gallopamil

Alternative Names: gallopamil
Clinical Status: Inactive
Latest Update: 2024-03-04
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Calcium Channel Blocker

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Germany | Italy | Pakistan | Portugal | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: CHU de Bordeaux
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Phase 2: Asthma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

REMODEL'ASTHME

P2

Completed

Asthma

2012-07-01

2019-03-18

Treatments

Remodel'asthme

P2

Active, not recruiting

Asthma

2012-06-24

2025-07-09

Treatments